| Product Code: ETC7662922 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The subcutaneous drug delivery devices import market in Israel saw a significant shift in concentration levels from moderate to high in 2024, driven by imports primarily from Metropolitan France, Switzerland, Italy, Canada, and the UK. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-2024 remained strong at 13.42%. This indicates a steady demand for subcutaneous drug delivery devices in Israel, with key exporting countries playing a crucial role in meeting this demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Subcutaneous Drug Delivery Devices Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Subcutaneous Drug Delivery Devices Market - Industry Life Cycle |
3.4 Israel Subcutaneous Drug Delivery Devices Market - Porter's Five Forces |
3.5 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Subcutaneous Drug Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel leading to higher demand for subcutaneous drug delivery devices |
4.2.2 Technological advancements in drug delivery systems improving efficacy and patient compliance |
4.2.3 Growing focus on home healthcare and self-administration of drugs driving the demand for convenient and easy-to-use devices |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of subcutaneous drug delivery devices leading to longer time to market |
4.3.2 High cost associated with development and manufacturing of advanced drug delivery devices |
4.3.3 Limited awareness and adoption of subcutaneous drug delivery devices among healthcare providers and patients |
5 Israel Subcutaneous Drug Delivery Devices Market Trends |
6 Israel Subcutaneous Drug Delivery Devices Market, By Types |
6.1 Israel Subcutaneous Drug Delivery Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Prefilled syringes, 2021- 2031F |
6.1.4 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Pen injectors, 2021- 2031F |
6.1.5 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Auto-injectors, 2021- 2031F |
6.1.6 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Wearable injectors, 2021- 2031F |
6.1.7 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Needle-free injectors, 2021- 2031F |
6.2 Israel Subcutaneous Drug Delivery Devices Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.2.3 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.2.4 Israel Subcutaneous Drug Delivery Devices Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
7 Israel Subcutaneous Drug Delivery Devices Market Import-Export Trade Statistics |
7.1 Israel Subcutaneous Drug Delivery Devices Market Export to Major Countries |
7.2 Israel Subcutaneous Drug Delivery Devices Market Imports from Major Countries |
8 Israel Subcutaneous Drug Delivery Devices Market Key Performance Indicators |
8.1 Adoption rate of subcutaneous drug delivery devices by healthcare facilities |
8.2 Number of clinical trials utilizing subcutaneous drug delivery devices in Israel |
8.3 Patient satisfaction and compliance rates with subcutaneous drug delivery devices |
8.4 Rate of reimbursement for subcutaneous drug delivery devices by health insurance providers in Israel |
9 Israel Subcutaneous Drug Delivery Devices Market - Opportunity Assessment |
9.1 Israel Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Subcutaneous Drug Delivery Devices Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Subcutaneous Drug Delivery Devices Market - Competitive Landscape |
10.1 Israel Subcutaneous Drug Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Israel Subcutaneous Drug Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |